Stifel
SF
$77.47
+0.40%
Stifel Financial Corp. is a diversified financial services provider generating revenue from wealth management, investment banking, and lending. Founded in 1890, it has transformed through acquisitions into a globally competitive wealth manager, investment bank, and brokerage. The current investor narrative centers on its revenue growth trajectory, margin expansion, and the impact of market volatility on its trading and investment banking segments.…
SF
Stifel
$77.47
Related headlines
Investment Opinion: Should I buy SF Today?
Rating: Buy. Stifel Financial is a value play with strong earnings momentum and a discounted valuation. The analyst consensus is Buy with an average target of $85.13, implying 10.3% upside, and the high target of $103 suggests 33.5% upside. The core thesis is that the company's earnings recovery is sustainable, driven by revenue growth and margin expansion, and the current valuation does not fully reflect this improvement.
Supporting evidence: Trailing PE of 13.3x is well below the industry average of 22x, and forward PE of 10.9x indicates expected earnings growth. Revenue grew 14.7% YoY in Q1 2026, accelerating from 1.5% a year ago. Operating margin improved to 32.6% from 4.4%, demonstrating strong operating leverage. TTM free cash flow of $831 million supports dividends and reinvestment. The PB ratio of 1.44x is below the industry average of 1.8x, further suggesting undervaluation.
Risks & Conditions: The biggest risks are a slowdown in revenue growth or a reversal in margin expansion. If revenue growth decelerates below 10% or operating margins fall below 20%, the stock could underperform. This Buy rating would be downgraded to Hold if the stock approaches the analyst average target of $85 without further catalysts, or if earnings estimates are revised downward. The stock appears undervalued relative to its history and peers, offering a margin of safety.
Sign up to view all
SF 12-Month Price Forecast
Stifel Financial's fundamentals are improving rapidly, with strong revenue growth and margin expansion driving earnings recovery. The stock's valuation is attractive relative to peers and its own history, offering a margin of safety. However, the stock has underperformed the market, and the cyclical nature of investment banking introduces uncertainty. The base case of reaching the analyst average target of $85 is most likely, but the bull case could materialize if market conditions remain favorable. I would upgrade to higher confidence if the stock breaks above its 52-week high of $89.83 or if earnings estimates are revised upward. Conversely, a downgrade to neutral would occur if revenue growth decelerates below 10% or margins contract.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Stifel's 12-month outlook, with a consensus price target around $85.13 and implied upside of +9.9% versus the current price.
Average Target
$85.13
0 analysts
Implied Upside
+9.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$75 - $103
Analyst target range
Eight analysts cover Stifel, with a consensus recommendation of Buy (mean 2.375 on a 1-5 scale where 1 is Strong Buy). The average target price is $85.13, implying 10.3% upside from the current price of $77.16. The distribution shows 4 Buy, 3 Hold, and 1 Sell, leaning bullish but with some caution. The target range spans from $75.00 (low) to $103.00 (high). The high target assumes strong earnings growth and multiple expansion, while the low target reflects downside risks from market volatility or margin compression. Recent ratings actions include UBS maintaining Buy, TD Cowen downgrading from Buy to Hold in January 2026, and Citigroup upgrading from Neutral to Buy in July 2025. The spread between low and high targets is 37%, indicating moderate uncertainty. The consensus EPS estimate for the current fiscal year is $7.97, with a range of $7.57 to $8.32, suggesting confidence in earnings recovery.
Bulls vs Bears: SF Investment Factors
Stifel Financial presents a compelling value opportunity with strong earnings recovery, accelerating revenue growth, and a discounted valuation relative to peers. The bull case is supported by a healthy balance sheet, improving margins, and analyst optimism. However, the stock has persistently underperformed the market, and its investment banking exposure introduces cyclical risk. The single most important tension is whether the earnings recovery is sustainable: if revenue growth and margin expansion continue, the stock could re-rate higher; if market conditions deteriorate, earnings could revert to 2025 levels, justifying the current low valuation. Currently, the bull case has stronger evidence given the fundamental improvements, but the market's skepticism requires patience.
Bullish
- Strong earnings recovery: Diluted EPS surged from $0.39 in Q1 2025 to $2.28 in Q1 2026, a 485% increase, driven by operating margin expansion from 4.4% to 32.6%. This demonstrates significant operating leverage and a return to profitability.
- Revenue growth accelerating: Q1 2026 revenue of $1.666 billion grew 14.7% year-over-year, accelerating from 1.5% growth in Q1 2025. Wealth management and investment banking fees are driving the uptick, with asset management fees at $459 million and investment banking at $341 million.
- Attractive valuation discount: Trailing PE of 13.3x and forward PE of 10.9x represent a 40% discount to the industry average PE of 22x. The PB ratio of 1.44x is also below the industry average of 1.8x, suggesting the stock is undervalued relative to peers.
- Healthy balance sheet: Debt-to-equity ratio of 0.36 is conservative, and the current ratio of 5.24 indicates strong liquidity. TTM free cash flow of $831 million provides ample cash for dividends and reinvestment.
Bearish
- Persistent underperformance vs S&P 500: The stock has a 1-year return of +5.59% versus the S&P 500's +18.35%, resulting in a relative strength of -12.76%. Over 6 months, the stock is down 10.76% while the market is up 7.46%, indicating sustained weakness.
- Cyclical investment banking exposure: Investment banking contributes roughly one-third of revenue, making earnings sensitive to market volatility and deal flow. Q1 2025 saw EPS of only $0.39 when markets were subdued, highlighting earnings variability.
- Negative free cash flow in Q1: Free cash flow was -$390 million in Q1 2026 due to working capital changes, which could signal cash flow volatility. While TTM FCF is positive, quarterly swings may concern investors.
- Low short ratio but potential for further downside: Short ratio of 0.01 is extremely low, indicating little bearish sentiment, but the stock is near the low end of its 52-week range (58% of range). A break below $67.81 support could trigger further selling.
SF Technical Analysis
The stock is in a range-bound consolidation phase, with a 1-year price change of +5.59% significantly underperforming the S&P 500's +18.35%. The current price of $77.16 sits at 58% of its 52-week range ($67.81-$89.83), indicating it is closer to the low end, which could suggest a value opportunity or reflect ongoing weakness. The 1-month change of +5.04% shows a short-term bounce, but the 6-month change of -10.76% highlights persistent downward pressure. Short-term momentum is diverging from the longer-term trend: the 1-month gain contrasts with the 3-month decline of -6.27%, suggesting a potential short-term reversal attempt within a broader downtrend. The relative strength versus the S&P 500 is negative across all periods, with a 1-year relative strength of -12.76%, confirming sustained underperformance. The 52-week low of $67.81 provides key support, while the 52-week high of $89.83 acts as resistance. A breakout above $89.83 would signal a bullish reversal, while a breakdown below $67.81 could accelerate selling. Beta of 1.011 indicates volatility roughly in line with the market, meaning the stock offers no significant diversification benefit in terms of volatility.
Beta
1.01
1.01x market volatility
Max Drawdown
-23.5%
Largest decline past year
52-Week Range
$68-$90
Price range past year
Annual Return
+5.7%
Cumulative gain past year
| Period | SF Return | S&P 500 |
|---|---|---|
| 1m | +5.3% | -0.6% |
| 3m | -5.8% | +5.4% |
| 6m | -9.7% | +8.3% |
| 1y | +5.7% | +18.3% |
| ytd | -9.4% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SF Fundamental Analysis
Revenue is growing, with Q1 2026 revenue of $1.666 billion up 14.7% year-over-year, accelerating from the 1.5% growth in Q1 2025. The trailing twelve-month revenue is approximately $6.51 billion, with wealth management contributing roughly two-thirds and investment banking one-third. The revenue growth is driven by asset management fees ($459 million) and investment banking ($341 million), while commissions ($208 million) provide additional support. Net income for Q1 2026 was $251 million, with diluted EPS of $2.28, up from $0.39 in Q1 2025, showing a strong profitability recovery. Gross margin is high at 82.8% (Q1 2026), typical for financial services, while operating margin improved to 32.6% from 4.4% a year ago, reflecting operating leverage. Net margin of 15.1% is solid and above the industry average for investment banks. The balance sheet is healthy: debt-to-equity ratio of 0.36 is conservative, and the current ratio of 5.24 indicates strong liquidity. Free cash flow was negative in Q1 2026 (-$390 million) due to working capital changes, but TTM free cash flow is $831 million, providing ample cash for dividends and reinvestment. ROE of 11.4% is reasonable for the sector.
Quarterly Revenue
$1.7B
2026-03
Revenue YoY Growth
+14.7%
YoY Comparison
Gross Margin
82.8%
Latest Quarter
Free Cash Flow
$830694000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SF Overvalued?
Since net income is positive, the PE ratio is the primary valuation metric. The trailing PE is 13.3x, while the forward PE is 10.9x, indicating the market expects earnings growth. The gap between trailing and forward PE suggests a 17% expected earnings increase, consistent with the improving profitability trend. Compared to the industry average PE of 22x (estimated), Stifel trades at a 40% discount, which may reflect its smaller scale and lower growth profile versus larger peers. The PB ratio of 1.44x is below the industry average of 1.8x, further suggesting a discount. Historically, the trailing PE of 13.3x is near the lower end of its 5-year range (roughly 5x-37x), indicating the stock is not expensive relative to its own history. The current valuation implies the market is pricing in cautious expectations, possibly due to cyclical risks in investment banking.
PE
13.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Stifel's debt-to-equity ratio of 0.36 is conservative, but the company's earnings are sensitive to market conditions, as evidenced by Q1 2025 EPS of $0.39 versus Q1 2026 EPS of $2.28. The negative free cash flow of -$390 million in Q1 2026, though partly due to working capital, could signal cash flow volatility. Net margin improved to 15.1% in Q1 2026, but the TTM net margin is 10.9%, showing variability. Revenue concentration in wealth management (two-thirds) and investment banking (one-third) means a downturn in either segment could significantly impact earnings.
Market & Competitive Risks: The stock trades at a trailing PE of 13.3x, a 40% discount to the industry average of 22x, which could reflect market skepticism about earnings sustainability. Beta of 1.011 indicates market-like volatility, offering no diversification benefit. The stock's 1-year relative strength of -12.76% versus the S&P 500 suggests persistent underperformance. Competitive pressures from larger investment banks and wealth managers could compress margins. Recent news about The Trade Desk's client dispute, while not directly related, highlights industry risks in financial services.
Worst-Case Scenario: A sustained market downturn could reduce investment banking revenue and asset management fees, causing earnings to revert to 2025 levels. If the stock breaks below the 52-week low of $67.81, it could fall further to the analyst low target of $75, representing a 2.8% downside from the current price of $77.16. However, in a severe recession, the stock could test the 52-week low of $67.81, a 12.1% decline. Historical max drawdown of -23.46% suggests a potential loss of up to 23.5% from current levels, implying a price of $59.06.
FAQ
The key risks include: 1) Cyclical earnings risk: Investment banking revenue is sensitive to market conditions, as seen in Q1 2025 when EPS was only $0.39. 2) Market underperformance: The stock has a 1-year relative strength of -12.76% versus the S&P 500, indicating persistent weakness. 3) Valuation risk: While the stock appears undervalued, the low PE may reflect structural challenges or lower growth expectations. 4) Cash flow volatility: Free cash flow was negative $390 million in Q1 2026, though TTM FCF is positive. The most severe risk is a market downturn that could push the stock to the 52-week low of $67.81, a 12.1% decline from current levels.
The 12-month forecast is moderately bullish. The base case (55% probability) expects the stock to reach the analyst average target of $85.13, implying 10.3% upside, driven by continued revenue growth and stable margins. The bull case (25% probability) sees the stock reaching $90-$103, assuming strong market conditions and multiple expansion. The bear case (20% probability) could see the stock fall to $68-$75 if a market downturn reduces earnings. The most likely scenario is the base case, supported by consensus EPS estimates of $7.97 and improving fundamentals. Key catalysts include the next earnings report and any positive changes in analyst ratings.
Stifel Financial appears undervalued based on both PE and PB ratios. The trailing PE of 13.3x is well below the industry average of 22x, and the forward PE of 10.9x suggests expected earnings growth. The PB ratio of 1.44x is also below the industry average of 1.8x. Historically, the trailing PE is near the lower end of its 5-year range (roughly 5x-37x), indicating the stock is not expensive relative to its own history. The current valuation implies the market is pricing in cautious expectations, possibly due to cyclical risks in investment banking. If the earnings recovery continues, the stock could re-rate higher, offering significant upside.
Stifel Financial appears to be a good buy for value-oriented investors with a moderate risk tolerance. The stock trades at a trailing PE of 13.3x, a 40% discount to the industry average of 22x, and offers a 10.3% upside to the analyst average target of $85.13. The company is experiencing a strong earnings recovery, with EPS rising from $0.39 to $2.28 year-over-year in the latest quarter. However, the stock has underperformed the market, and its investment banking exposure makes it cyclical. For investors who believe the earnings recovery is sustainable, the current valuation provides a margin of safety. The biggest downside risk is a market downturn that could reduce earnings, potentially sending the stock to the 52-week low of $67.81.
Stifel Financial is better suited for long-term investment due to its cyclical nature and current valuation discount. The stock has a beta of 1.011, indicating market-like volatility, and has underperformed the market over the past year. However, the company's strong balance sheet, dividend yield of 2.84%, and earnings recovery make it attractive for long-term holders who can tolerate short-term fluctuations. Short-term traders may find opportunities around earnings announcements, but the stock's range-bound behavior suggests limited near-term upside. A minimum holding period of 12-18 months is recommended to allow the earnings recovery to materialize and the market to re-rate the stock.